在海南自贸港即将开启全岛封关运作的关键历史节点，12月11日至13日，"2025第十四届上市公司发展 年会暨海南自贸港开放机遇交流大会"在海口举办。在同期举办的2025资本市场荣誉盛典上，药师帮从 数千家公司中脱颖而出，荣膺"大健康卓越竞争力上市公司"，彰显了资本市场对公司高质量发展的认 可。 在此趋势下，药师帮探索出一套智慧供应链模式，以推动医药交易与服务的数字化革新，为医药流通产 业链的智慧升级提出了新的思路。根据弗若斯特沙利文的资料，以2021年商品交易总额规模衡量，药师 帮是中国院外医药产业规模领先的数字化综合服务平台。作为院外医药与医疗服务市场数字化的推动 者，公司已率先利用科技连接赋能上游（包括药企及分销商）及下游（包括药店及基层医疗机构），让 医药交易与服务实现数字化、标准化及规模化的重塑性变革，构建起规模领先的数字化医药交易与服务 网络。 展望未来，作为院外医药产业数字化生态建设的引领者，药师帮将凭借深厚的行业积累以及卓越的技术 创新能力，在院外医药数字化变革的浪潮中勇立潮头。公司将进一步深化与产业链各环节参与者的协同 合作，全面提升产业链各参与者的经营效能，推动院外医药产业的数字化、智能化升 ...

Company Overview - Yaoshi Bang Co., Ltd. was established in 2015 and is the largest digital comprehensive service platform in China's outpatient pharmaceutical industry [3] - The company aims to empower participants in the outpatient pharmaceutical market through digitalization, including pharmaceutical companies, distributors, pharmacies, and grassroots medical institutions [3] - Yaoshi Bang's mission is to make quality medical products and services accessible at fair and transparent prices, enhancing the overall efficiency of the healthcare ecosystem [3] Financial Performance - As of December 31, 2024, Yaoshi Bang achieved total revenue of 17.904 billion yuan, representing a year-on-year growth of 5.49% [1] - The net profit attributable to shareholders was 30.013 million yuan, showing a significant year-on-year increase of 100.94% [1] - The gross profit margin stood at 10.13%, with a debt-to-asset ratio of 65.07% [1] Market Position and Valuation - Currently, there are no institutional investment ratings for Yaoshi Bang [2] - The average price-to-earnings (P/E) ratio for the pharmaceutical and biotechnology industry is 5.22 times, with a median of 4.58 times [2] - Yaoshi Bang's P/E ratio is significantly higher at 137.82 times, ranking 77th in the industry [2] - Comparatively, other companies in the sector have much lower P/E ratios, such as Qingyou Pharmaceutical at 0.72 times and Jinsui Biotechnology at 1.03 times [2] Business Scale and Reach - In 2023, Yaoshi Bang's total Gross Merchandise Volume (GMV) reached 46.9 billion yuan, covering 401,000 pharmacies and 246,000 grassroots medical institutions [3] - The company penetrates 98.6% of county-level areas and 88.4% of townships nationwide, with an average of 367,000 active buyers per month [3] - Yaoshi Bang has established the largest digital pharmaceutical trading and service network in the country [3]